A Black alderperson called a white alderperson racist, then suggested they settle their differences “outside.” Depending on your point of view, this might have been upsetting or entertaining to those ...

Pursuing a traditional approval path for bitopertin in erythropoietic protoporphyria (EPP); Phase 3 APOLLO study is expected to complete enrollment in March 2026 with topline data expected in Q4 ...

What Businesses Should Know About Deconstruction Opportunities in the Coming Weeks St Louis, United States - February ...

Full year 2025 ORLADEYO® net revenue of $601.8 million (+38% y-o-y; +43% y-o-y excluding European ORLADEYO revenue following ...

Opera Limited (NASDAQ: OPRA), a leading global browser and AI agent company, today announced financial results for the quarter and full year ended December 31, 2025.

NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this ...

NEWARK, CA / ACCESS Newswire / February 25, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) (“Protagonist” or “the Company”) today reported financial results for the fourth quarter and full year ended ...

A new publication DOI 10.29026/oes.2026.250031, discusses an integrated metasurface-freeform system enabled multi-focal ...

Good morning, ladies and gentlemen, and welcome to the Chord Energy Fourth Quarter 2025 Earnings Call Conference Call. [Operator Instructions] This call is being recorded on Thursday, February 26, ...

The U.S. Food and Drug Administration (FDA) has cleared an investigational new drug application from FluoGuide A/S in Copenhagen, Denmark, allowing the company to move forward in the U.S. with a ...

Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced ...

Plan maximizes free cash flow and strengthens balance sheetAccelerates return of capital, including a 10% dividend increase, ...